Selected research
Market Structure
Global Prosthetic Heart Valve & Artificial Heart Valve Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Prosthetic Heart Valve & Artificial Heart Valve market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Prosthetic Heart Valve & Artificial Heart Valve is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Prosthetic Heart Valve & Artificial Heart Valve is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Prosthetic Heart Valve & Artificial Heart Valve is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Prosthetic Heart Valve & Artificial Heart Valve is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Prosthetic Heart Valve & Artificial Heart Valve include Medtronic Plc, Medtronic, Boston Scientific Corporation, TTK Healthcare Limited (A Ttk Group Company), Ttk Healthcare Limited, Symetis Sa, Symetis, St. Jude Medical, Inc. (An Abbott Laboratories Company) and St. Jude Medical Inc. (Abbott Laboratories Company), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Prosthetic Heart Valve & Artificial Heart Valve market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Prosthetic Heart Valve & Artificial Heart Valve and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Prosthetic Heart Valve & Artificial Heart Valve sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prosthetic Heart Valve & Artificial Heart Valve market size, projected growth trends, production technologies, key applications, and end-use industries.
Prosthetic Heart Valve & Artificial Heart Valve Segment by Company
Medtronic Plc
Medtronic
Boston Scientific Corporation
TTK Healthcare Limited (A Ttk Group Company)
Ttk Healthcare Limited
Symetis Sa
Symetis
St. Jude Medical, Inc. (An Abbott Laboratories Company)
St. Jude Medical Inc. (Abbott Laboratories Company)
Micro Interventional Devices
Meril Life Sciences
Livanova Plc
Livanova Plc
Lepu Medical Technology Co., Ltd.
Lepu Medical Technology
Labcor Laboratório
Jenavalve Technology, Inc.
Jenavalve Technology Inc.
HLT Inc. (A Bracco Group Company)
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
Cryolife, Inc.
Cryolife Inc.
Comed B.V.
Colibri Heart Valve, Llc
Colibri Heart Valve
Braile Biomédica
Braile Biomédica
Boston Scientific Corporation
Autotissue Berlin Gmbh
Prosthetic Heart Valve & Artificial Heart Valve Segment by Type
Mechanical Heart Valve
Transcatheter Heart Valve
Tissue Heart Valve
Prosthetic Heart Valve & Artificial Heart Valve Segment by Application
Congenital Heart Disease
Marfan Syndrome
Rheumatic Heart Disease
Other
Prosthetic Heart Valve & Artificial Heart Valve Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prosthetic Heart Valve & Artificial Heart Valve market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prosthetic Heart Valve & Artificial Heart Valve and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prosthetic Heart Valve & Artificial Heart Valve.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Prosthetic Heart Valve & Artificial Heart Valve market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prosthetic Heart Valve & Artificial Heart Valve manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prosthetic Heart Valve & Artificial Heart Valve in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Prosthetic Heart Valve & Artificial Heart Valve in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Mechanical Heart Valve
- Transcatheter Heart Valve
- Tissue Heart Valve
Applications
- Congenital Heart Disease
- Marfan Syndrome
- Rheumatic Heart Disease
- Other
Companies covered
- Medtronic Plc
- Medtronic
- Boston Scientific Corporation
- TTK Healthcare Limited (A Ttk Group Company)
- Ttk Healthcare Limited
- Symetis Sa
- Symetis
- St. Jude Medical, Inc. (An Abbott Laboratories Company)
- St. Jude Medical Inc. (Abbott Laboratories Company)
- Micro Interventional Devices
- Meril Life Sciences
- Livanova Plc
- Livanova Plc
- Lepu Medical Technology Co., Ltd.
- Lepu Medical Technology
- Labcor Laboratório
- Jenavalve Technology, Inc.
- Jenavalve Technology Inc.
- HLT Inc. (A Bracco Group Company)
- Edwards Lifesciences Corporation
- Edwards Lifesciences Corporation
- Cryolife, Inc.
- Cryolife Inc.
- Comed B.V.
- Colibri Heart Valve, Llc
- Colibri Heart Valve
- Braile Biomédica
- Braile Biomédica
- Boston Scientific Corporation
- Autotissue Berlin Gmbh
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Prosthetic Heart Valve & Artificial Heart Valve Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Prosthetic Heart Valve & Artificial Heart Valve Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Prosthetic Heart Valve & Artificial Heart Valve Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Prosthetic Heart Valve & Artificial Heart Valve Market Dynamics
- 2.1 Prosthetic Heart Valve & Artificial Heart Valve Industry Trends
- 2.2 Prosthetic Heart Valve & Artificial Heart Valve Industry Drivers
- 2.3 Prosthetic Heart Valve & Artificial Heart Valve Industry Opportunities and Challenges
- 2.4 Prosthetic Heart Valve & Artificial Heart Valve Industry Restraints
3 Prosthetic Heart Valve & Artificial Heart Valve Market by Manufacturers
- 3.1 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Manufacturers (2021-2026)
- 3.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Manufacturers (2021-2026)
- 3.3 Global Prosthetic Heart Valve & Artificial Heart Valve Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Prosthetic Heart Valve & Artificial Heart Valve Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Prosthetic Heart Valve & Artificial Heart Valve Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Prosthetic Heart Valve & Artificial Heart Valve Manufacturers, Product Type & Application
- 3.7 Global Prosthetic Heart Valve & Artificial Heart Valve Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Prosthetic Heart Valve & Artificial Heart Valve Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Prosthetic Heart Valve & Artificial Heart Valve Players Market Share by Revenue in 2025
- 3.8.3 2025 Prosthetic Heart Valve & Artificial Heart Valve Tier 1, Tier 2, and Tier 3
4 Prosthetic Heart Valve & Artificial Heart Valve Market by Type
- 4.1 Prosthetic Heart Valve & Artificial Heart Valve Type Introduction
- 4.1.1 Mechanical Heart Valve
- 4.1.2 Transcatheter Heart Valve
- 4.1.3 Tissue Heart Valve
- 4.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Type
- 4.2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Type (2021-2032)
- 4.2.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Type (2021-2032)
- 4.3 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Type
- 4.3.1 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Type (2021-2032)
- 4.3.3 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Type (2021-2032)
5 Prosthetic Heart Valve & Artificial Heart Valve Market by Application
- 5.1 Prosthetic Heart Valve & Artificial Heart Valve Application Introduction
- 5.1.1 Congenital Heart Disease
- 5.1.2 Marfan Syndrome
- 5.1.3 Rheumatic Heart Disease
- 5.1.4 Other
- 5.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Application
- 5.2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Application (2021-2032)
- 5.2.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Application (2021-2032)
- 5.3 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Application
- 5.3.1 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Application (2021-2032)
- 5.3.3 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Application (2021-2032)
6 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region
- 6.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region (2021-2032)
- 6.2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region (2021-2026)
- 6.2.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Prosthetic Heart Valve & Artificial Heart Valve Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Prosthetic Heart Valve & Artificial Heart Valve Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Prosthetic Heart Valve & Artificial Heart Valve Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Region
- 7.1 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Region
- 7.1.1 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Region (2021-2026)
- 7.1.3 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Region (2027-2032)
- 7.1.4 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Prosthetic Heart Valve & Artificial Heart Valve Revenue (2021-2032)
- 7.2.2 North America Prosthetic Heart Valve & Artificial Heart Valve Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Prosthetic Heart Valve & Artificial Heart Valve Revenue (2021-2032)
- 7.3.2 Europe Prosthetic Heart Valve & Artificial Heart Valve Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Prosthetic Heart Valve & Artificial Heart Valve Revenue (2021-2032)
- 7.4.2 Asia-Pacific Prosthetic Heart Valve & Artificial Heart Valve Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Medtronic Plc
- 8.1.1 Medtronic Plc Company Information
- 8.1.2 Medtronic Plc Business Overview
- 8.1.3 Medtronic Plc Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Medtronic Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.1.5 Medtronic Plc Recent Developments
- 8.2 Medtronic
- 8.2.1 Medtronic Company Information
- 8.2.2 Medtronic Business Overview
- 8.2.3 Medtronic Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Medtronic Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.2.5 Medtronic Recent Developments
- 8.3 Boston Scientific Corporation
- 8.3.1 Boston Scientific Corporation Company Information
- 8.3.2 Boston Scientific Corporation Business Overview
- 8.3.3 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.3.5 Boston Scientific Corporation Recent Developments
- 8.4 TTK Healthcare Limited (A Ttk Group Company)
- 8.4.1 TTK Healthcare Limited (A Ttk Group Company) Company Information
- 8.4.2 TTK Healthcare Limited (A Ttk Group Company) Business Overview
- 8.4.3 TTK Healthcare Limited (A Ttk Group Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 TTK Healthcare Limited (A Ttk Group Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.4.5 TTK Healthcare Limited (A Ttk Group Company) Recent Developments
- 8.5 Ttk Healthcare Limited
- 8.5.1 Ttk Healthcare Limited Company Information
- 8.5.2 Ttk Healthcare Limited Business Overview
- 8.5.3 Ttk Healthcare Limited Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Ttk Healthcare Limited Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.5.5 Ttk Healthcare Limited Recent Developments
- 8.6 Symetis Sa
- 8.6.1 Symetis Sa Company Information
- 8.6.2 Symetis Sa Business Overview
- 8.6.3 Symetis Sa Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Symetis Sa Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.6.5 Symetis Sa Recent Developments
- 8.7 Symetis
- 8.7.1 Symetis Company Information
- 8.7.2 Symetis Business Overview
- 8.7.3 Symetis Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Symetis Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.7.5 Symetis Recent Developments
- 8.8 St. Jude Medical, Inc. (An Abbott Laboratories Company)
- 8.8.1 St. Jude Medical, Inc. (An Abbott Laboratories Company) Company Information
- 8.8.2 St. Jude Medical, Inc. (An Abbott Laboratories Company) Business Overview
- 8.8.3 St. Jude Medical, Inc. (An Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 St. Jude Medical, Inc. (An Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.8.5 St. Jude Medical, Inc. (An Abbott Laboratories Company) Recent Developments
- 8.9 St. Jude Medical Inc. (Abbott Laboratories Company)
- 8.9.1 St. Jude Medical Inc. (Abbott Laboratories Company) Company Information
- 8.9.2 St. Jude Medical Inc. (Abbott Laboratories Company) Business Overview
- 8.9.3 St. Jude Medical Inc. (Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 St. Jude Medical Inc. (Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.9.5 St. Jude Medical Inc. (Abbott Laboratories Company) Recent Developments
- 8.10 Micro Interventional Devices
- 8.10.1 Micro Interventional Devices Company Information
- 8.10.2 Micro Interventional Devices Business Overview
- 8.10.3 Micro Interventional Devices Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Micro Interventional Devices Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.10.5 Micro Interventional Devices Recent Developments
- 8.11 Meril Life Sciences
- 8.11.1 Meril Life Sciences Company Information
- 8.11.2 Meril Life Sciences Business Overview
- 8.11.3 Meril Life Sciences Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Meril Life Sciences Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.11.5 Meril Life Sciences Recent Developments
- 8.12 Livanova Plc
- 8.12.1 Livanova Plc Company Information
- 8.12.2 Livanova Plc Business Overview
- 8.12.3 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.12.5 Livanova Plc Recent Developments
- 8.13 Livanova Plc
- 8.13.1 Livanova Plc Company Information
- 8.13.2 Livanova Plc Business Overview
- 8.13.3 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.13.5 Livanova Plc Recent Developments
- 8.14 Lepu Medical Technology Co., Ltd.
- 8.14.1 Lepu Medical Technology Co., Ltd. Company Information
- 8.14.2 Lepu Medical Technology Co., Ltd. Business Overview
- 8.14.3 Lepu Medical Technology Co., Ltd. Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Lepu Medical Technology Co., Ltd. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.14.5 Lepu Medical Technology Co., Ltd. Recent Developments
- 8.15 Lepu Medical Technology
- 8.15.1 Lepu Medical Technology Company Information
- 8.15.2 Lepu Medical Technology Business Overview
- 8.15.3 Lepu Medical Technology Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Lepu Medical Technology Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.15.5 Lepu Medical Technology Recent Developments
- 8.16 Labcor Laboratório
- 8.16.1 Labcor Laboratório Company Information
- 8.16.2 Labcor Laboratório Business Overview
- 8.16.3 Labcor Laboratório Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Labcor Laboratório Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.16.5 Labcor Laboratório Recent Developments
- 8.17 Jenavalve Technology, Inc.
- 8.17.1 Jenavalve Technology, Inc. Company Information
- 8.17.2 Jenavalve Technology, Inc. Business Overview
- 8.17.3 Jenavalve Technology, Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Jenavalve Technology, Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.17.5 Jenavalve Technology, Inc. Recent Developments
- 8.18 Jenavalve Technology Inc.
- 8.18.1 Jenavalve Technology Inc. Company Information
- 8.18.2 Jenavalve Technology Inc. Business Overview
- 8.18.3 Jenavalve Technology Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Jenavalve Technology Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.18.5 Jenavalve Technology Inc. Recent Developments
- 8.19 HLT Inc. (A Bracco Group Company)
- 8.19.1 HLT Inc. (A Bracco Group Company) Company Information
- 8.19.2 HLT Inc. (A Bracco Group Company) Business Overview
- 8.19.3 HLT Inc. (A Bracco Group Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 HLT Inc. (A Bracco Group Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.19.5 HLT Inc. (A Bracco Group Company) Recent Developments
- 8.20 Edwards Lifesciences Corporation
- 8.20.1 Edwards Lifesciences Corporation Company Information
- 8.20.2 Edwards Lifesciences Corporation Business Overview
- 8.20.3 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.20.5 Edwards Lifesciences Corporation Recent Developments
- 8.21 Edwards Lifesciences Corporation
- 8.21.1 Edwards Lifesciences Corporation Company Information
- 8.21.2 Edwards Lifesciences Corporation Business Overview
- 8.21.3 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.21.4 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.21.5 Edwards Lifesciences Corporation Recent Developments
- 8.22 Cryolife, Inc.
- 8.22.1 Cryolife, Inc. Company Information
- 8.22.2 Cryolife, Inc. Business Overview
- 8.22.3 Cryolife, Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.22.4 Cryolife, Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.22.5 Cryolife, Inc. Recent Developments
- 8.23 Cryolife Inc.
- 8.23.1 Cryolife Inc. Company Information
- 8.23.2 Cryolife Inc. Business Overview
- 8.23.3 Cryolife Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.23.4 Cryolife Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.23.5 Cryolife Inc. Recent Developments
- 8.24 Comed B.V.
- 8.24.1 Comed B.V. Company Information
- 8.24.2 Comed B.V. Business Overview
- 8.24.3 Comed B.V. Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.24.4 Comed B.V. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.24.5 Comed B.V. Recent Developments
- 8.25 Colibri Heart Valve, Llc
- 8.25.1 Colibri Heart Valve, Llc Company Information
- 8.25.2 Colibri Heart Valve, Llc Business Overview
- 8.25.3 Colibri Heart Valve, Llc Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.25.4 Colibri Heart Valve, Llc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.25.5 Colibri Heart Valve, Llc Recent Developments
- 8.26 Colibri Heart Valve
- 8.26.1 Colibri Heart Valve Company Information
- 8.26.2 Colibri Heart Valve Business Overview
- 8.26.3 Colibri Heart Valve Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.26.4 Colibri Heart Valve Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.26.5 Colibri Heart Valve Recent Developments
- 8.27 Braile Biomédica
- 8.27.1 Braile Biomédica Company Information
- 8.27.2 Braile Biomédica Business Overview
- 8.27.3 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.27.4 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.27.5 Braile Biomédica Recent Developments
- 8.28 Braile Biomédica
- 8.28.1 Braile Biomédica Company Information
- 8.28.2 Braile Biomédica Business Overview
- 8.28.3 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.28.4 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.28.5 Braile Biomédica Recent Developments
- 8.29 Boston Scientific Corporation
- 8.29.1 Boston Scientific Corporation Company Information
- 8.29.2 Boston Scientific Corporation Business Overview
- 8.29.3 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.29.4 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.29.5 Boston Scientific Corporation Recent Developments
- 8.30 Autotissue Berlin Gmbh
- 8.30.1 Autotissue Berlin Gmbh Company Information
- 8.30.2 Autotissue Berlin Gmbh Business Overview
- 8.30.3 Autotissue Berlin Gmbh Prosthetic Heart Valve & Artificial Heart Valve Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.30.4 Autotissue Berlin Gmbh Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
- 8.30.5 Autotissue Berlin Gmbh Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Prosthetic Heart Valve & Artificial Heart Valve Value Chain Analysis
- 9.1.1 Prosthetic Heart Valve & Artificial Heart Valve Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Prosthetic Heart Valve & Artificial Heart Valve Production Mode & Process
- 9.2 Prosthetic Heart Valve & Artificial Heart Valve Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Prosthetic Heart Valve & Artificial Heart Valve Distributors
- 9.2.3 Prosthetic Heart Valve & Artificial Heart Valve Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst